STOCK TITAN

[SCHEDULE 13G/A] Northrop Grumman Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Capital International Investors reports beneficial ownership of 12,385,281 shares of Northrop Grumman Corporation common stock, equal to 8.6% of 143,928,185 shares believed outstanding. The filing is a Schedule 13G (Amendment No. 8) for CUSIP 666807102 and shows sole voting power for 12,218,846 shares and sole dispositive power for 12,385,281 shares.

The filing includes a certification that the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The statement is signed by Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company, dated 08/12/2025.

Capital International Investors dichiara la titolarità effettiva di 12,385,281 azioni ordinarie della Northrop Grumman Corporation, pari al 8.6% di 143,928,185 azioni ritenute in circolazione. La comunicazione è un Schedule 13G (Emendamento n. 8) relativo al CUSIP 666807102 e indica potere di voto esclusivo su 12,218,846 azioni e potere esclusivo di disposizione su 12,385,281 azioni.

La comunicazione include una certificazione secondo cui le azioni sono detenute nell'ordinaria attività d'impresa e non sono state acquisite per modificare o influenzare il controllo dell'emittente. La dichiarazione è firmata da Jae Won Chung, Vice President e Senior Counsel II di Capital Research and Management Company, in data 08/12/2025.

Capital International Investors informa la propiedad beneficiaria de 12,385,281 acciones ordinarias de Northrop Grumman Corporation, equivalentes al 8.6% de 143,928,185 acciones que se cree están en circulación. La presentación es un Schedule 13G (Enmienda n.º 8) para el CUSIP 666807102 y muestra poder de voto exclusivo sobre 12,218,846 acciones y poder dispositivo exclusivo sobre 12,385,281 acciones.

La presentación incluye una certificación de que las acciones se mantienen en el curso ordinario del negocio y no fueron adquiridas para cambiar o influir en el control del emisor. La declaración está firmada por Jae Won Chung, Vice President y Senior Counsel II de Capital Research and Management Company, con fecha 08/12/2025.

Capital International Investors는 Northrop Grumman Corporation 보통주 12,385,281주에 대한 실소유권을 보고하며, 이는 유통주식으로 추정되는 143,928,185주 중 8.6%에 해당합니다. 이 제출서는 CUSIP 666807102에 대한 Schedule 13G(수정 제8호)이며 단독 의결권은 12,218,846주, 단독 처분권은 12,385,281주로 기재되어 있습니다.

제출서에는 해당 주식이 영업의 통상적인 범위에서 보유되고 있으며 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아님을 인증하는 내용이 포함되어 있습니다. 이 진술서는 Capital Research and Management Company의 부사장 겸 수석 고문 II인 Jae Won Chung이 서명했으며 날짜는 08/12/2025입니다.

Capital International Investors déclare la propriété bénéficiaire de 12,385,281 actions ordinaires de Northrop Grumman Corporation, soit 8.6% des 143,928,185 actions estimées en circulation. Le dépôt est un Schedule 13G (Amendement n° 8) pour le CUSIP 666807102 et indique un pouvoir de vote exclusif pour 12,218,846 actions et un pouvoir exclusif de disposition pour 12,385,281 actions.

Le dépôt comprend une attestation que les actions sont détenues dans le cours normal des affaires et n'ont pas été acquises dans le but de changer ou d'influencer le contrôle de l'émetteur. La déclaration est signée par Jae Won Chung, Vice President et Senior Counsel II chez Capital Research and Management Company, datée du 08/12/2025.

Capital International Investors meldet wirtschaftliches Eigentum an 12,385,281 Aktien der Stammaktien von Northrop Grumman Corporation, was 8.6% von geschätzten 143,928,185 ausstehenden Aktien entspricht. Die Einreichung ist ein Schedule 13G (Nachtrag Nr. 8) für CUSIP 666807102 und weist alleiniges Stimmrecht für 12,218,846 Aktien sowie alleiniges Verfügungsrecht für 12,385,281 Aktien aus.

Die Einreichung enthält eine Bescheinigung, dass die Aktien im gewöhnlichen Geschäftsverkehr gehalten werden und nicht zum Zwecke der Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden. Die Erklärung ist von Jae Won Chung, Vice President und Senior Counsel II bei Capital Research and Management Company, unterzeichnet und datiert 08/12/2025.

Positive
  • Institutional stake of 12,385,281 shares (8.6% of outstanding) disclosed
  • Sole voting power reported for 12,218,846 shares, indicating consolidated voting control within the position
  • Certification of passive ownership (held in ordinary course and not to influence control) clarifies intent
Negative
  • None.

Insights

TL;DR: A material 8.6% institutional stake is disclosed; Schedule 13G filing indicates passive ownership, limiting immediate control implications.

The filing documents that Capital International Investors beneficially owns 12,385,281 shares (8.6%) of Northrop Grumman and holds sole voting power over 12,218,846 shares. Because this is a Schedule 13G with a certification that the position is held in the ordinary course and not to influence control, the report signals a substantial passive position rather than an active control attempt. For investors, the key metrics are the 8.6% stake and the concentrated sole voting/dispositive power noted in the filing.

TL;DR: Sole voting and dispositive power are noteworthy for governance, but the filer certifies no intent to change control.

The statement shows Capital International Investors exercises sole voting authority on the majority of its reported holdings, which gives it the capacity to vote meaningfully on shareholder matters. However, the filing's certification explicitly states the shares are held in the ordinary course of business and not to influence control, consistent with a passive institutional investor reporting under Rule 13d-1(b). From a governance perspective, this is material ownership to monitor but does not by itself indicate activist intent.

Capital International Investors dichiara la titolarità effettiva di 12,385,281 azioni ordinarie della Northrop Grumman Corporation, pari al 8.6% di 143,928,185 azioni ritenute in circolazione. La comunicazione è un Schedule 13G (Emendamento n. 8) relativo al CUSIP 666807102 e indica potere di voto esclusivo su 12,218,846 azioni e potere esclusivo di disposizione su 12,385,281 azioni.

La comunicazione include una certificazione secondo cui le azioni sono detenute nell'ordinaria attività d'impresa e non sono state acquisite per modificare o influenzare il controllo dell'emittente. La dichiarazione è firmata da Jae Won Chung, Vice President e Senior Counsel II di Capital Research and Management Company, in data 08/12/2025.

Capital International Investors informa la propiedad beneficiaria de 12,385,281 acciones ordinarias de Northrop Grumman Corporation, equivalentes al 8.6% de 143,928,185 acciones que se cree están en circulación. La presentación es un Schedule 13G (Enmienda n.º 8) para el CUSIP 666807102 y muestra poder de voto exclusivo sobre 12,218,846 acciones y poder dispositivo exclusivo sobre 12,385,281 acciones.

La presentación incluye una certificación de que las acciones se mantienen en el curso ordinario del negocio y no fueron adquiridas para cambiar o influir en el control del emisor. La declaración está firmada por Jae Won Chung, Vice President y Senior Counsel II de Capital Research and Management Company, con fecha 08/12/2025.

Capital International Investors는 Northrop Grumman Corporation 보통주 12,385,281주에 대한 실소유권을 보고하며, 이는 유통주식으로 추정되는 143,928,185주 중 8.6%에 해당합니다. 이 제출서는 CUSIP 666807102에 대한 Schedule 13G(수정 제8호)이며 단독 의결권은 12,218,846주, 단독 처분권은 12,385,281주로 기재되어 있습니다.

제출서에는 해당 주식이 영업의 통상적인 범위에서 보유되고 있으며 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아님을 인증하는 내용이 포함되어 있습니다. 이 진술서는 Capital Research and Management Company의 부사장 겸 수석 고문 II인 Jae Won Chung이 서명했으며 날짜는 08/12/2025입니다.

Capital International Investors déclare la propriété bénéficiaire de 12,385,281 actions ordinaires de Northrop Grumman Corporation, soit 8.6% des 143,928,185 actions estimées en circulation. Le dépôt est un Schedule 13G (Amendement n° 8) pour le CUSIP 666807102 et indique un pouvoir de vote exclusif pour 12,218,846 actions et un pouvoir exclusif de disposition pour 12,385,281 actions.

Le dépôt comprend une attestation que les actions sont détenues dans le cours normal des affaires et n'ont pas été acquises dans le but de changer ou d'influencer le contrôle de l'émetteur. La déclaration est signée par Jae Won Chung, Vice President et Senior Counsel II chez Capital Research and Management Company, datée du 08/12/2025.

Capital International Investors meldet wirtschaftliches Eigentum an 12,385,281 Aktien der Stammaktien von Northrop Grumman Corporation, was 8.6% von geschätzten 143,928,185 ausstehenden Aktien entspricht. Die Einreichung ist ein Schedule 13G (Nachtrag Nr. 8) für CUSIP 666807102 und weist alleiniges Stimmrecht für 12,218,846 Aktien sowie alleiniges Verfügungsrecht für 12,385,281 Aktien aus.

Die Einreichung enthält eine Bescheinigung, dass die Aktien im gewöhnlichen Geschäftsverkehr gehalten werden und nicht zum Zwecke der Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden. Die Erklärung ist von Jae Won Chung, Vice President und Senior Counsel II bei Capital Research and Management Company, unterzeichnet und datiert 08/12/2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Capital International Investors
Signature:Jae Won Chung
Name/Title:Vice President and Senior Counsel II, Capital Research and Management Company
Date:08/12/2025

FAQ

How many Northrop Grumman (NOC) shares does Capital International Investors report owning?

The filing reports beneficial ownership of 12,385,281 shares.

What percentage of NOC does the 13G/A filing represent?

The reported position represents 8.6% of the 143,928,185 shares believed to be outstanding.

Does the filing indicate voting or dispositive power for the shares?

Yes. The filer reports sole voting power for 12,218,846 shares and sole dispositive power for 12,385,281 shares.

What type of Schedule was filed and what does it state about intent?

A Schedule 13G (Amendment No. 8) was filed, and it includes a certification that the shares are held in the ordinary course of business and not to change or influence control.

Who signed the filing and when was it signed?

The filing is signed by Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company, dated 08/12/2025.
Northrop Grumman

NYSE:NOC

NOC Rankings

NOC Latest News

NOC Latest SEC Filings

NOC Stock Data

83.08B
142.86M
0.22%
85.05%
1.86%
Aerospace & Defense
Search, Detection, Navagation, Guidance, Aeronautical Sys
Link
United States
FALLS CHURCH